Johnson & Johnson on Thursday raised its revenue and earnings guidance for 2020 compared with forecasts it had issued in April.
The global health-products giant now expects adjusted earnings per share of $7.75 to $7.95 for the year, compared with the earlier forecast of $7.50 to $7.90. Analysts polled by FactSet were anticipating adjusted earnings per share of $7.75.
J&J now expects 2020 revenue of $79.9 billion to $81.4 billion, up from the prior guidance range of $77.5 billion to $80.5 billion. Analysts had forecast revenue of $79.77 billion.
The company says the new guidance includes the estimated impact of the coronavirus pandemic.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.